Insider filing · LGND
John W Kozarich
Director
profile →
Ligand Pharmaceuticals Incorporated
LGND · Healthcare · 36 filings in 24 months
ticker →
John W Kozarich sold $455K of Ligand Pharmaceuticals Incorporated (LGND)
Executed May 12, disclosed May 14, 2 days later.
Value, as filed
$455K
2,034 sh across 2 lots
Executed
May 12
the trade date, as filed
Disclosed
May 14
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JKJohn W Kozarich (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Ligand Pharmaceuticals Incorporated (LGND). The largest single filing was $455K of LGND (2,034 sh across 2 lots, as filed), executed May 12.
The name
LGNDHealthcare · Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by John W Kozarich in LGND
LGNDSALE
Ligand Pharmaceuticals Incorporated
$117K934 sh × $125.00
Exec Jul 10 2025
Filed Jul 11 2025 · 5:30 PM ET